Engineering Tumor Hypersusceptibility to Checkpoint Immunotherapy.
Trends Cancer. 2017 Oct;3(10):675-677. doi: 10.1016/j.trecan.2017.08.002. Epub 2017 Sep 4.
Trends Cancer. 2017.
PMID: 28958385
Review.